IP Library Granted Patent US 8,287,909
Granted Patent B2
US 8,287,909 · App. 12/336,755 · Granted Oct 16, 2012

Medical devices containing melt-blown non-wovens of poly-4-hydroxybutyrate and copolymers thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,287,909
App. No.
12/336,755
Granted
Oct 16, 2012
Kind
B2
Abstract

Continuous processing methods for making absorbable polymeric non-wovens with one or more of the following properties: high burst strength, fine fibers of average diameter from 1 μm to 50 μm, and thickness from 10 μm to 50 mm, have been developed. Improved fiber cohesion is made possible by allowing the fibers of the non-woven to initially remain molten during web collection. In the preferred embodiment, the polymer is a polyhydroxyalkanoate, and in the most preferred embodiment, the polymer comprises 4-hydroxybutyrate. A particularly preferred embodiment is a non-woven of poly-4-hydroxybutyrate or copolymer thereof, wherein the non-woven has a burst strength greater than 0.1 Kgf, wherein the non-woven is derived by a continuous melt-blown process. The non-wovens can be used for a variety of purposes including fabrication of medical devices.

Claims (22)

1. A non-woven comprising fibers of poly-4-hydroxybutyrate or copolymer thereof having a weight average molecular weight greater than 50,000 g/mol,

the fibers having an average diameter of from about 1 μm to about 50 μm,

wherein the non-woven has a burst strength greater than 0.1 Kgf, and

wherein the non-woven is derived by a melt blown process comprising

melt extruding a poly-4-hydroxybutyrate or copolymer polymer at a temperature between 60° C. and 275° C.,

conveying the poly-4-hydroxybutyrate or copolymer into a multiple hole spinneret, and

attenuating the extruded polymer strands with high velocity air at a temperature of 100-300° C.

2. The non-woven of claim 1 wherein the non-woven has a thickness of 10 μm to 5 mm.

3. The non-woven of claim 1 wherein the fibers of the non-woven fused together during web collection.

4. The non-woven of claim 1 formed into a device.

5. The non-woven of claim 4 in the form of a device or component of a device selected from the group consisting of a stent, stent graft, stent coating, drug delivery device, device for temporary wound or tissue support, repair patch, tissue engineering scaffold, retention membrane, anti-adhesion membrane, tissue separation membrane, hernia repair device, device coating, cardiovascular patch, catheter balloon, vascular closure device, sling, biocompatible coating, rotator cuff repair device, meniscus repair device, adhesion barrier, guided tissue repair/regeneration device, articular cartilage repair device, nerve guide, tendon repair device, intracardiac septal defect repair device, left atrial appendage (LAA) closure device, pericardial patch, bulking and filling agent, vein valve, heart valve, bone marrow scaffold, meniscus regeneration device, ligament and tendon graft, ocular cell implant, spinal fusion device, imaging device, skin substitute, dural substitute, bone graft substitute, wound dressing, and hemostat.

6. The non-woven of claim 1 wherein the non-woven is a bi-component non-woven, further comprising a second thermoplastic polymer.

7. The non-woven of claim 1 further comprising one or more prophylactic, diagnostic, or therapeutic agents.

8. The non-woven of claim 7 wherein the diagnostic agents are selected from the group consisting of radiolabelled substances, imaging agents, radiopaque markers, and contrast agents.

9. The non-woven of claim 1 further comprising one or more materials selected from the group consisting of other polymers, protein, plasticizers, nucleants, compatibilizers, porogens, anti-oxidants, dyes, viscosity modifiers, and odor control agents.

10. A method of producing a non-woven of poly-4-hydroxybutyrate or copolymer thereof, wherein the non-woven comprises fine fibers having an average diameter of from about 1 μm to about 50 μm, and a burst strength greater than 0.1 Kgf, comprising

deriving the non-woven by melt-blown processing of the polymer by melt extrusion at a temperature between 60° C. and 275° C.,

conveying the poly-4-hydroxybutyrate or copolymer into a multiple hole spinneret, and

attenuating the extruded polymer strands with high velocity air at a temperature of 100-300° C., wherein the poly-4-hydroxybutyrate or copolymer has a weight average molecular weight greater than 50,000 g/mol.

11. The method of claim 10 comprising forming a non-woven while the fibers are molten, wherein the fibers fuse at their crossover points as the polymer solidifies.

12. The method of claim 10 further comprising forming the non-woven into a device or component of a device selected from the group consisting of a stent, stent graft, stent coating, drug delivery device, device for temporary wound or tissue support, repair patch, tissue engineering scaffold, retention membrane, anti-adhesion membrane, tissue separation membrane, hernia repair device, device coating, cardiovascular patch, catheter balloon, vascular closure device, sling, biocompatible coating, rotator cuff repair device, meniscus repair device, adhesion barrier, guided tissue repair/regeneration device, articular cartilage repair device, nerve guide, tendon repair device, intracardiac septal defect repair device, left atrial appendage (LAA) closure device, pericardial patch, bulking and filling agent, vein valve, heart valve, bone marrow scaffold, meniscus regeneration device, ligament and tendon graft, ocular cell implant, spinal fusion device, imaging device, skin substitute, dural substitute, bone graft substitute, wound dressing, and hemostat.

13. A method of using the device of claim 12 , comprising implanting or administering the device at a site in or on a patient in need thereof.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 5, 2023
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
To: TEPHA, INC.
Reel/Frame 065156/0223 →
SECURITY INTEREST Recorded Oct 23, 2020
From: TEPHA, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 054224/0693 →
RELEASE OF SECURITY INTEREST Recorded Sep 28, 2017
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: TEPHA, INC.
Reel/Frame 043731/0714 →
SECURITY AGREEMENT Recorded Jun 28, 2010
From: TEPHA, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 024599/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2009
From: MARTIN, DAVID P.; RIZK, SAID; HO, KICHERL; WILLIAMS, SIMON F.
To: TEPHA, INC.
Reel/Frame 022225/0447 →